The FDA commissioner has emphasized the potential of real-time clinical trials to revolutionize the drug development process.
This approach would allow regulators to monitor clinical trials as they unfold, accessing endpoint data in real-time via cloud technology.
Such advancements could lead to more informed regulatory decisions and potentially accelerate the approval of new therapies.